- 投稿方式--官网投稿
-
期刊属性
-
- 中科分区:3区
- OA期刊:混合
-
- 综述期刊:否
- TOP期刊:否
-
- 期均国文:1
- 环比增速:-50.00%


-
期刊信息
- 研究方向:医学-BIOTECHNOLOGY APPLIED MICROBIOLOGY 生物工程与应用微生物;GENETICS HEREDITY 遗传学;MEDICINE, RESEARCH EXPERIMENTAL 医学:研究与实验
- 国际刊号:ISSN1043-0342;EISSN1557-7422
-
- 期刊语言:英语
- 出版地区:美国
- 投稿网址:https://mc.manuscriptcentral.com/hum
- 电子邮箱:
- 期刊官网:https://home.liebertpub.com/publications/human-gene-therapy/19/
- 作者指南:
- 出版商网址:http://www.liebertpub.com/
- 出版地址:MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801
- 期刊简介:HUMAN GENE THERAPY《人类基因治疗》(半月刊). Human Gene Therapy (HGT) is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes important advances in DNA, RNA, cell and immune therapies, validating the latest advances in research and new technologies.
-
万维提示
-
1、投稿方式:在线投稿。
2、期刊网址:
https://home.liebertpub.com/publications/human-gene-therapy/19/
3、投稿网址:https://mc.manuscriptcentral.com/hum
4、官网邮箱:HGT_EO@liebertpub.com(编辑部)
5、期刊刊期:半月刊,一年出版24期。
2021年8月26日星期四
投稿须知【官网信息】
Human Gene Therapy
For Authors
Journal Information
Manuscript Submission Site: https://mc.manuscriptcentral.com/hum
Editorial Office Contact: HGT_EO@liebertpub.com
Support Contact: prosupport@liebertpub.com
Journal Model: Hybrid
Blinding: Single Blind
File formatting requirement stage: On revision. Format neutral on original submission.
Instant Online Option (immediate publication of accepted version): Yes
Submission Fee: None
Average time to initial decision: 21 days
About the Journal
Human Gene Therapy will consider manuscripts of very high quality that broadly fall under the scope of cell and gene therapy. Some general categories include studies evaluating novel approaches of cell and gene therapy in pre-clinical and clinical models; development of novel technologies; studies that help define mechanisms of action of cell and gene therapies; host interactions to vector and transplanted cells; and high-impact new methods and clinical trials.
Manuscripts on these topics may be submitted in the form of an original research article or a high impact protocol. Invited review articles and commentaries are usually solicited by the Editorial Board, but we also welcome unsolicited submissions of this type.
The Editors may quickly reject a manuscript soon after submission without external review if it falls outside the scope of the Journal or would not likely meet our high standards required for publication.
Manuscript Types and Guidelines
Original Research Articles
3,000-word limit
Unstructured abstract of no more than 300 words
Maximum of six (6) tables and/or figures
Review Articles
5,000-8,000-word limit
Unstructured abstract of no more than 300 words
Maximum of four (4) tables and/or figures
A maximum of 50 references is permitted
Research Articles- Methods
3,000-word limit
Unstructured abstract of no more than 300 words
Maximum of six (6) tables and/or figures
Research Articles – Clinical Development
3,000-word limit
Unstructured abstract of no more than 300 words
Maximum of six (6) tables and/or figures
Methods Protocols
3,000-word limit
Unstructured abstract of no more than 100 words
Maximum of six (6) tables and/or figures
Clinical Protocols
4,500-word limit
Unstructured abstract of no more than 300 words
Maximum of six (6) tables and/or figures
Pathways in Gene Therapy
2,000-word limit
No abstract
Maximum of two (2) tables and/or figures
Commentaries
1,200-word limit
No abstract
No tables or figures
News and Views
1,000-word limit
No abstract
No tables or figures
Letters to the Editor
500-word limit
May include one figure OR table
Reference citations are identical in style to those of full original articles, but should not exceed five (5).
Word limits do NOT pertain to the abstract, disclosure statements, author contribution statements, funding information, acknowledgments, tables, figure legends, or references.
Human Gene Therapy welcomes format-neutral manuscripts for first-time submissions. Newly submitted manuscripts will not be un-submitted for formatting issues. However, after the initial peer review process, revised submissions must follow correct journal formatting and file guidelines, as described below in the Instructions for Authors. Please note that there are certain compulsory elements (i.e.: IRB approvals, author disclosures, etc.) that must be included in all new submissions. Manuscripts submitted without this information will be un-submitted and the submitting author will be asked to add the required components.
……
更多详情:
https://home.liebertpub.com/publications/human-gene-therapy/19/for-authors
- Contemporary Physics《当代物理学》
- Discrete Analysis《离散分析》
- Chemical Industry & Chemical Engineering Quarterly《化学工业与化学工程
- ARP Rheumatology《ARP风湿病学》(原:Acta Reumatologica Portuguesa)
- ZFW-Advances in Economic Geography《ZFW:经济地理学进展》(原:Zeitschrif
- Yale Journal of Biology and Medicine《耶鲁生物学与医学杂志》
- Turkish Journal of Zoology《土耳其动物学杂志》
- Turkish Journal of Veterinary & Animal Sciences《土耳其兽医与动物科学杂志
- The Turkish Journal of Pediatrics《土耳其儿科杂志》
- Turkish Journal of Medical Sciences《土耳其医学杂志》
- Reproductive Sciences《生殖科学》
- Rejuvenation Research《抗衰老研究》
- Die Radiologie《放射学》(原:Der Radiologe)
- Quarterly Reviews of Biophysics《生物物理学评论季刊》
- Psychiatry and Clinical Neurosciences《精神病学与临床神经科学》
- Preventive Veterinary Medicine《预防兽医学》
- Physics of Particles and Nuclei《粒子核物理学》
- Numerical Linear Algebra with Applications《数值线性代数及其应用》
- Nanoscale and Microscale Thermophysical Engineering《微/纳尺度热物理
- Matrix Biology《基质生物学》